Fundraising FoxIovance Biotherapeutics
Philadelphia, US · 2 known investors
Find your way into Iovance Biotherapeutics
Sign up to see every warm intro you have to Iovance Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iovance Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
Investors · 2
Founder mafia
3 people who came through Iovance Biotherapeutics went on to found or lead other companies.
Frequently asked questions
- What does Iovance Biotherapeutics do?
- Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
- Who are Iovance Biotherapeutics's investors?
- Iovance Biotherapeutics's investors include Avoro Capital Advisors, Frazier Life Sciences.
- Where is Iovance Biotherapeutics headquartered?
- Iovance Biotherapeutics is headquartered in Philadelphia, US.